Blue Review
A newsletter for contracting institutional and professional providers

September 2019

Faulty Neulasta Onpro Devices: Billing and Reimbursement Reminders

The Neulasta Onpro device makes life a little easier for chemotherapy patients by allowing them to administer the drug Neulasta at home. When a device fails, the patient must go to the doctor’s office for the injection to avoid infection.

As a reminder, if this happens, a failed device may not be reimbursable. Please check with the manufacturer or contact your distributor for information on failed devices and drug waste.

As always, only administered drugs along with appropriately related wastage are eligible for billing. Billing that resembles duplicate payment for a failed device may be indicated on your statement and may be recouped. If this occurs, please contact the manufacturer for possible replacement.